Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - dutasteridum, tamsulosini hydrochloridum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, e 171, glycerolum, triglycerida media, lecithinum ex soja, tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulato per la realizzazione di una soluzione orale - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - malattie infettive - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

dr. andres pharma ag - symphyti radicis recentis extractum ethanolicum liquidum (symphytum officinale l., radix) - gel - symphyti radicis recentis extractum ethanolicum liquidum (symphytum officinale l., radix) 160 mg, der: 1:1.6-2.1, auszugsmittel ethanolum 59% (v/v) cum 0.6 % ammoniae solutio concentrata 25% (m/m), glycerolum (85 per centum), carbomer interpolymer, ammoniae solutio concentrata 25% (m/m), aqua purificata, propylis parahydroxybenzoas natricus 0.45 mg, e 219 1.05 mg, ad gelatum 1 g, corresp. ethanolum 73 mg. - coadiuvante il trattamento in caso di disturbi reumatici, ottuso traumi - phytoarzneimittel

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - pomalidomidum - capsule rigide - pomalidomidum 1 mg, mannitolum, amylum pregelificatum, natrii stearylis fumaras corresp. natrium 0.018 mg, kapselhülle: gelatina, e 171, e 132, e 172 (flavum), drucktinte: lacca, e 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - il trattamento del mieloma multiplo - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulato per la realizzazione di una soluzione orale - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - malattie infettive - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - nitrofurantoinum - capsule - nitrofurantoinum 100 mg, lactosum monohydricum 20 mg, hypromellosum, cellulosum microcristallinum, kapselhülle: gelatina, e 104, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - infezioni del tratto urinario - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - compresse - levodopum 200.00 mg, benserazidum 50.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.01 mg, magnesii stearas, pro compresso. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - compresse - levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, e 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.005 mg, magnesii stearas, pro compresso. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, hypromellosum, oleum vegetabile hydrogenatum, calcii hydrogenophosphas, mannitolum, povidonum k 30, talcum, magnesii stearas, kapselhülle: e 132, e 171, gelatina, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (rubrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Schweiz - italienska - Swissmedic (Swiss Agency for Therapeutic Products)

viiv healthcare gmbh - zidovudinum - capsule - zidovudinum 250 mg, amyla, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, aqua purificata, kalii hydroxidum, pro capsula corresp. natrium 0.588 - 0.882 mg. - le infezioni da hiv - synthetika